Relationship between metabolically healthy obesity and the prevalence of non-alcoholic fatty liver disease

Abstract

Abstract: Objective To investigate the role of metabolically normal obesity in non-alcoholic fatty liver disease(NAFLD). Methods From 2011 to 2012, a cross-section survey with 4 757 participants enrolled from four communities in Wenzhou was conducted. Data collection was conducted through questionnaire survey, physical examination, laboratory examination, and multiple logistic regression analysis was used to comprehensively identify the risk factors of NAFLD. Results 1 068 individuals(22.4%) were diagnosed as metabolically healthy obesity. The prevalence of NAFLD was 43.5%. Among the various obesity phenotypes, the proportions ranked from high to low were metabolically unhealthy obese(MUO), metabolically unhealthy nonobese(MUNO), metabolically healthy obese(MHO) and metabolically healthy nonobese(MHNO). Obesity was defined by waist circumference and BMI, the risk of NAFLD in MHO population was 3.38 times(95% CI:2.13-5.37) and 4.69 times(95% CI:3.01-7.16) higher than that of MHNO, respectively. Conclusions MHO is associated with an increased risk of NAFLD in the Chinese population. It is necessary to screen for NAFLD in obese subjects regardless state of metabolic health.

Key words: metabolically healthy obesity, non-alcoholic fatty liver disease, waist circumference, BMI

CLC Number:

R589.2

XU Ke, HU Xiang, YU Wei-hui, YANG Li-juan, GU Xue-jiang. Relationship between metabolically healthy obesity and the prevalence of non-alcoholic fatty liver disease[J]. Basic & Clinical Medicine, 2021, 41(6): 837-841.

References

[1] Rinella ME. Nonalcoholic fatty liver disease: a systematic review[J]. JAMA, 2015, 313: 2263-2273.
[2] Adams LA, Anstee QM, Tilg H, et al. Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases[J]. Gut, 2017, 66: 1138-1153.
[3] Allen AM, Thernaeu TM, Larson JJ, et al. Nonalcoholic fatty liver disease incidence and impact on metabolic burden and death: a 20 year-community study[J]. Hepatology, 2018, 67: 1726-1736.
[4] Eslam M, Newsome PN, Sarin SK, et al. A new defini-tion for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement[J]. Hepatology, 2020, 73: 202-209.
[5] Lynch LA, O'connell JM, Kwasnik AK, et al. Are natural killer cells protecting the metabolically healthy obese patient?[J]. Obesity(Silver Spring, Md), 2009, 17: 601-605.
[6] Targher G, Byrne CD. Obesity: Metabolically healthy obesity and NAFLD[J]. Nat Rev Gastroenterol Hepatol, 2016, 13: 442-444.
[7] Ning G. Risk evaluation of cancers in Chinese diabetic individuals: a longitudinal study[J]. Diabetes, 2012, 4: 172-173.
[8] Zimmet P, K George MMA, Serrano Rios M. A new international diabetes federation worldwide definition of the metabolic syndrome: the rationale and the results[J]. Rev Esp Cardiol, 2005, 58: 1371-1376.
[9] Rey-L PezJ P, DE Rezende LF, Pastor-Valero M, et al. The prevalence of metabolically healthy obesity: a systematic review and critical evaluation of the definitions used[J]. Obes Rev, 2014, 15: 781-790.
[10] Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity[J]. Circulation, 2009, 120: 1640-1645.
[11] Leitzmann MF, Moore SC, Koster A, et al. Waist circumference as compared with body-mass index in predicting mortality from specific causes[J]. PLoS One, 2011, 6: e18582.doi:10.1371/journal.pone.0018582.
[12] Bl Her M. Metabolically healthy obesity[J]. Endocr Rev, 2020, 41: 405-420.
[13] Wu LM, He H, Chen G, et al. Associations between obesity and metabolic health with nonalcoholic fatty liver disease in elderly Chinese[J]. Hepatobiliary Pancreat Dis Int, 2020, 19: 252-257.
[14] Fabbrini E, Sullivan S, Klein S. Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications[J]. Hepatology, 2010, 51: 679-689.
[15] Soriguer F, Guti Rrez-Repiso C, Rubio-Mart NE, et al. Metabolically healthy but obese, a matter of time? Findings from the prospective Pizarra study[J]. J Clin Endocrinol Metab, 2013, 98: 2318-2325.